Pay close attention to PARADIGM (PAR). 3 Potential Moves
1. We bounce off the .382 Fib level and return to test the 2.80 mark which we saw on 11/05/20
-Being the end of the trading week I suspect the latter.
2. We break the .382 Fib level and Uptrend and head for the 'Golden Pocket'
-Bounce off strong support at 2.00 mark
-MACD is starting to squeeze but if we...
We just checked pharmacies around the North East
PALFORZIA peanut allergy drug is available at CVS Pharmacy and is being filled at CVS Pharmacy
CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations with over 9,600 pharmacies throughout the United States.
Its parent company ranks as the 7th largest U.S. corporation by...
I'm getting bad vibes on the news for tomorrow in this one. This is based on my dowsing work and it suggests a drop of 38%. That would rock it down to about $42.50
FYI I don't know anything about the fundamentals or background on this pending approval, and I really don't know anything about the company, nor do I care.
I'm not super confident yet in...
This idea comes from recent success in a Sprint trade. It was slow in coming, but it did come through very successfully, which is the impetus for this idea of "reading" tickers with binary events.
This is purely a news driven idea in which there is no technical reading of the chart what-so-ever. I have no idea if this will be correct, and am really using this...
Lannett stock has struggled lately due to opioid litigation and a weakening of its earnings forecast back in November. However, the company announced several product launches in December and early January, and today Lannett got FDA approval for, of all things, a cocaine-based anesthetic nasal spray. The stock has shown little positive reaction to any of this news,...
$KDMN is set up well both technically and fundamentally. The FDA just approved CLOVIQUE (TM), A Room-Temperature Stable Trientine Hydrochloride Product. This bodes well for the company as it moves forward. According to the press release:
Product Offers Room Temperature Stability, Improving Convenience for Patients
NEW YORK, NY / ACCESSWIRE / October 21, 2019 /...